| human | Q5 |
| P496 | ORCID iD | 0000-0001-5592-3839 |
| P108 | employer | University of Helsinki | Q28695 |
| P106 | occupation | researcher | Q1650915 |
| Q45125767 | Array comparative genomic hybridization reveals frequent alterations of G1/S checkpoint genes in undifferentiated pleomorphic sarcoma of bone |
| Q37078506 | Combined use of expression and CGH arrays pinpoints novel candidate genes in Ewing sarcoma family of tumors |
| Q44561705 | Copy number alterations and neoplasia-specific mutations in MELK, PDCD1LG2, TLN1, and PAX5 at 9p in different neoplasias |
| Q54712822 | Frequent deletion of CDKN2A and recurrent coamplification of KIT, PDGFRA, and KDR in fibrosarcoma of bone--an array comparative genomic hybridization study. |
| Q57001391 | Genetic analysis of fibrosarcoma of bone, a rare tumour entity closely related to osteosarcoma and malignant fibrous histiocytoma of bone |
| Q60548455 | Malignant fibrous histiocytoma of bone: Analysis of genomic imbalances by comparative genomic hybridisation and C-MYC expression by immunohistochemistry |
| Q34325539 | Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. |
| Q39869264 | Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome |
| Q36707302 | The Role of Chromosomal Instability and Epigenetics in Colorectal Cancers Lacking β-Catenin/TCF Regulated Transcription |
| Q39465507 | miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy |
Search more.